Stroke Trial, Recruiting NCT06368648 Sponsor: CoMind Technologies Limited Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06368648
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are male or female (by birth) and are 18 years old or older at the time of joining the trial.
  • You are already receiving continuous brain pressure monitoring through an invasive device (such as a bolt or drain) as part of your normal medical care.
  • The brain pressure monitoring device goes into the brain tissue or the fluid-filled spaces of the brain.
  • You are already receiving continuous blood pressure monitoring through an invasive device as part of your normal medical care.

Who may not be able to join:

  • You have any implant (for cosmetic or other reasons) in the forehead bone that is close enough to potentially touch the study's sensor device.
  • You have open wounds on your forehead that would prevent the study's sensor from being safely placed on unbroken skin.
  • Scans taken when you were admitted to hospital show that the skull at the area where the sensor would be placed is not fully intact.
  • You are taking part in another study or receiving a treatment that could interfere with your standard brain pressure monitoring or with the study's sensor device.
  • Your skull has had a section surgically removed, unless the study's sensor can be placed on a part of the skull that is still intact.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ramani Balu, MD, PhD, Inova Fairfax Hospital

Phone: 305-290-1680

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CoMind Technologies Limited
Registry
ClinicalTrials.gov
Start date
27 November 2024
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

A test of the difference in estimation errors between two non-invasive ICP estimation models: one trained with ABP and CoMind One EFS CBFi, and one trained only using ABP; Models trained using CoMind CBFi and ABP will be evaluated based on their limits of agreement (LOA) with invasive ICP.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov